It’s not often that such a market rally, now nearly 2 months in the making, can frighten investors, but this particular rally has served to uncover some strange happenstance when we look under the hood. With the FOMC/Fed on the sidelines and a China/U.S. trade deal seemingly on the horizon, the market fundamentals will eventually have to stand on their…
The Market is Safe, So Long As You Identify Its Pain Points
A financial market resource for the every-day investor and trader.
-
The Weakest Week: 3 More Headwinds?
Seth Golden, , Research Reports, 0
September is very much living up to its usual swooning of price action, and finding investors recoiling. The seasonality...
-
Morgan Stanley Biotechnology Team: Year-End Vaccine Probable
Seth Golden, , Research Reports, 0
Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is...
-
Why the US money supply is shrinking for the first time in 74 years
Seth Golden, , Research Reports, 0
The U.S. money supply is shrinking for the first time since 1949, as savings deposits decline and the Federal...
-
Weekly Warm-up: Earnings Take Center Stage with Valuation
Seth Golden, , Research Reports, 0
Our new Fed forecast simply brings forward our call for lower equity valuations and raises the risk in the...
-
J.P. Morgan MacroView Into Q3 2021 Quarter-End
Seth Golden, , Research Reports, 0
Markets to continue following the path of COVID recovery Cross-asset Strategy: Risk markets recovered from the technical sell-off, as...
-
Markets Are Doing Little More Than Chopping Wood
Seth Golden, , Research Reports, 0
The past trading week almost mirrored what we saw 2 weeks ago when the S&P 500 (SPX) fell in...
-
The Bears Beating Recession Drums as Q2 2018 Earnings Season Kicks Off
Seth Golden, , Research Reports, 0
In this week’s research report we are going to cover a few topics. The first topic centers on the...
-
Fundstrat 2024 Outlook
Seth Golden, , Research Reports, 0
In 2023, the S&P 500 gained 20% yet most investors sat on the sidelines as many expected the U.S....
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00